246 related articles for article (PubMed ID: 23099479)
1. Effective treatment of edema and endothelial barrier dysfunction with imatinib.
Aman J; van Bezu J; Damanafshan A; Huveneers S; Eringa EC; Vogel SM; Groeneveld AB; Vonk Noordegraaf A; van Hinsbergh VW; van Nieuw Amerongen GP
Circulation; 2012 Dec; 126(23):2728-38. PubMed ID: 23099479
[TBL] [Abstract][Full Text] [Related]
2. Abl family kinases regulate endothelial barrier function in vitro and in mice.
Chislock EM; Pendergast AM
PLoS One; 2013; 8(12):e85231. PubMed ID: 24367707
[TBL] [Abstract][Full Text] [Related]
3. Novel mechanisms for maintaining endothelial barrier function in sepsis.
Penn MS; Kamath M
Circulation; 2012 Dec; 126(23):2677-9. PubMed ID: 23212995
[No Abstract] [Full Text] [Related]
4. Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.
Letsiou E; Rizzo AN; Sammani S; Naureckas P; Jacobson JR; Garcia JG; Dudek SM
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L259-69. PubMed ID: 25480336
[TBL] [Abstract][Full Text] [Related]
5. Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.
Rizzo AN; Aman J; van Nieuw Amerongen GP; Dudek SM
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1071-9. PubMed ID: 25814671
[TBL] [Abstract][Full Text] [Related]
6. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
7. Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability.
Fainaru O; Adini I; Benny O; Bazinet L; Pravda E; D'Amato R; Folkman J
FASEB J; 2008 Oct; 22(10):3728-35. PubMed ID: 18606869
[TBL] [Abstract][Full Text] [Related]
8. Silencing of C5a receptor gene with siRNA for protection from Gram-negative bacterial lipopolysaccharide-induced vascular permeability.
Liu ZM; Zhu SM; Qin XJ; Cheng ZD; Liu MY; Zhang HM; Liu DX
Mol Immunol; 2010 Mar; 47(6):1325-33. PubMed ID: 20138669
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo.
Fürst R; Bubik MF; Bihari P; Mayer BA; Khandoga AG; Hoffmann F; Rehberg M; Krombach F; Zahler S; Vollmar AM
Mol Pharmacol; 2008 Jul; 74(1):1-8. PubMed ID: 18413663
[TBL] [Abstract][Full Text] [Related]
10. Negative-feedback loop attenuates hydrostatic lung edema via a cGMP-dependent regulation of transient receptor potential vanilloid 4.
Yin J; Hoffmann J; Kaestle SM; Neye N; Wang L; Baeurle J; Liedtke W; Wu S; Kuppe H; Pries AR; Kuebler WM
Circ Res; 2008 Apr; 102(8):966-74. PubMed ID: 18323527
[TBL] [Abstract][Full Text] [Related]
11. Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury.
Mu S; Liu Y; Jiang J; Ding R; Li X; Li X; Ma X
Respir Res; 2018 Nov; 19(1):220. PubMed ID: 30442128
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
[TBL] [Abstract][Full Text] [Related]
13. Imatinib ameliorates fibrosis in uraemic cardiac disease in BALB/c without improving cardiac function.
Baumann M; Leineweber K; Tewiele M; Wu K; Türk TR; Su S; Gössl M; Buck T; Wilde B; Heemann U; Kribben A; Witzke O
Nephrol Dial Transplant; 2010 Jun; 25(6):1817-24. PubMed ID: 20061323
[TBL] [Abstract][Full Text] [Related]
14. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
[TBL] [Abstract][Full Text] [Related]
15. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
[TBL] [Abstract][Full Text] [Related]
16. Sildenafil preserves lung endothelial function and prevents pulmonary vascular remodeling in a rat model of diastolic heart failure.
Yin J; Kukucka M; Hoffmann J; Sterner-Kock A; Burhenne J; Haefeli WE; Kuppe H; Kuebler WM
Circ Heart Fail; 2011 Mar; 4(2):198-206. PubMed ID: 21216837
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal regulation of endothelial substrate adhesion and barrier function.
Alexander JS; Zhu Y; Elrod JW; Alexander B; Coe L; Kalogeris TJ; Fuseler J
Microcirculation; 2001 Dec; 8(6):389-401. PubMed ID: 11781812
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma and interleukin-10 reciprocally regulate endothelial junction integrity and barrier function.
Oshima T; Laroux FS; Coe LL; Morise Z; Kawachi S; Bauer P; Grisham MB; Specian RD; Carter P; Jennings S; Granger DN; Joh T; Alexander JS
Microvasc Res; 2001 Jan; 61(1):130-43. PubMed ID: 11162203
[TBL] [Abstract][Full Text] [Related]
19. Ropivacaine inhibits pressure-induced lung endothelial hyperpermeability in models of acute hypertension.
Patel M; Chignalia AZ; Isbatan A; Bommakanti N; Dull RO
Life Sci; 2019 Apr; 222():22-28. PubMed ID: 30822427
[TBL] [Abstract][Full Text] [Related]
20. Arg mediates LPS-induced disruption of the pulmonary endothelial barrier.
Rizzo AN; Belvitch P; Demeritte R; Garcia JGN; Letsiou E; Dudek SM
Vascul Pharmacol; 2020; 128-129():106677. PubMed ID: 32240815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
